RhumbLine Advisers’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
RhumbLine Advisers's ALT Position: Q3 2026 in Review
RhumbLine Advisers increased its Altimmune (ALT) stake by 3.5% in Q3 2026, buying an estimated $33K and bringing the position to 320,348 shares worth $916K. The position accounts for ﹤0.01% of the portfolio, ranked #2328.
RhumbLine Advisers first reported a position in ALT in Q2 2016 and has held it in 22 quarters since. The position peaked at $941K in Q2 2026. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- RhumbLine Advisers held 320,348 shares of Altimmune worth $916K as of Q3 2026.
- RhumbLine Advisers bought 10,742 Altimmune shares in Q3 2026, an estimated $33K.
- Altimmune made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2328 holding.
- RhumbLine Advisers first reported a position in Altimmune in Q2 2016 and has held it in 22 quarters since.
- RhumbLine Advisers's Altimmune position peaked at $941K in Q2 2026.
- 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.